The Psychoanalytic Treatment of Psychosis in the Community
You are cordially invited to attend a presentation co-sponsored by the Kedzie Center and the Chicago Center for Psychoanalysis.
To be held at the Kedzie Center 4141 N, Kedzie Ave. Chicago
Wednesday, November 14 6-7:30 pm
The possibility of psychoanalytic treatment of psychosis in the community is actualized when:
1 – Psychosis is conceived of as a basic human structure – not an illness characterized by deficiency – allows for a reconsideration of the dimensions of chronicity and intractability demonstrated by established clinical work.
2 – As exemplified by a video that depicts an existing program known as “388”, located in Quebec City - where psychotics, afforded the opportunity for psychotics to profoundly reorganize their lives engaging in psychoanalysis. The results obtained demonstrate that 60% engaged in psychoanalysis gained a productive and satisfying place in their community.
3 – There will follow a discussion of the concept, the program and what would be required to establish such a program locally.
Presenter: Charles Turk, M.D. Psychiatrist at the Kedzie Center, a faculty member of the Chicago Center for Psychoanalysis and an analyst of GIFRIC - the organization that developed “388”
1 – Participants will become familiar with how the ethic of “best practices” demands consideration of results obtained as demonstrated by an innovative psychoanalytic treatment in a psychoanalytically informed program, and with what clinical, organizational and financial issues would have to be addressed to develop such a program locally.
2 – Participants will gain increased knowledge of how the prevailing “scientistic” view of psychosis that regards it as a “brain disease” obliterates the subject – and how this concept makes us human and offers an alternative viewpoint of psychosis.
3 – Participants will become familiar with how psychoanalysis as conducted at “388” offers psychotics a way to engage in a total reorganization of their personality and their lives.
This presentation will be of medium level interest to graduate students, clinicians and other professionals